Effects of pulmonary rehabilitation in patients with COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023180

Enrollment

100

Registered

2020-10-01

Start date

2020-04-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 COVID-19

Interventions

Group 1: The patients underwent a usual 3-week inpatient pulmonary rehabilitation with a focus on training therapy, respiratory physiotherapy, patient information and psychosocial support. Data are c

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: All patients who are assigned to pulmonary rehabilitation because of COVID-19.

Exclusion criteria

Exclusion criteria: Insufficient German language skills.

Design outcomes

Primary

Measure	Time frame
Dyspnea (numerical rating scale 0 (no dyspnea) to 10 (max. Dyspnea) at T1 (start of rehabilitation), T2 (end of rehabilitation) and 3 and 6 months after the end of rehabilitation.	—

Secondary

Measure	Time frame
Numerical rating scales for cough, sputum, and pain. 6-minute walking distance, lung function (VC), Blood gas analysis, oxygen saturation. Quality of life questionnaire (EQ 5D) and other questionnaires concerning fatigue (BFI), depression (PHQ-9), anxiety (GAD-7) and other subjective outcomes.	—

Countries

Germany

Contacts

Public ContactKonrad Schultz

Klinik Bad Reichenhall der DRV Bayern Süd

konrad.schultz@klinik-bad-reichenhall.de08651709535

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026